Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access
pharmaphorum
JANUARY 21, 2022
Medical science is accelerating at a tremendous rate, leading to profound changes in the treatment landscape for many diseases over the last decade. “It And the bottom line is that the patient may not receive a medicine that could save or substantially improve his or her life.”. Flawed funding model. WHO is OMI? Finding solutions.
52 
Let's personalize your content